Literature DB >> 20008141

Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Miguel A Gama Sosa1, Rita De Gasperi, Anne B Rocher, Athena Ching-Jung Wang, William G M Janssen, Tony Flores, Gissel M Perez, James Schmeidler, Dara L Dickstein, Patrick R Hof, Gregory A Elder.   

Abstract

Mutations in the presenilin 1 (PS1) gene are the most commonly recognized cause of familial Alzheimer's disease (FAD). Besides senile plaques, neurofibrillary tangles, and neuronal loss, Alzheimer's disease (AD) is also accompanied by vascular pathology. Here we describe an age-related vascular pathology in two lines of PS1 FAD-mutant transgenic mice that mimics many features of the vascular pathology seen in AD. The pathology was especially prominent in the microvasculature whose vessels became thinned and irregular with the appearance of many abnormally looped vessels as well as string vessels. Stereologic assessments revealed a reduction of the microvasculature in the hippocampus that was accompanied by hippocampal atrophy. The vascular changes were not congophilic. Yet, despite the lack of congophilia, penetrating vessels at the cortical surface were often abnormal morphologically and microhemorrhages sometimes occurred. Altered immunostaining of blood vessels with basement membrane-associated antigens was an early feature of the microangiopathy and was associated with thickening of the vascular basal laminae and endothelial cell alterations that were visible ultrastructurally. Interestingly, although the FAD-mutant transgene was expressed in neurons in both lines of mice, there was no detectable expression in vascular endothelial cells or glial cells. These studies thus have implications for the role of neuronal to vascular signaling in the pathogenesis of the vascular pathology associated with AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008141      PMCID: PMC2797896          DOI: 10.2353/ajpath.2010.090482

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  Length measurement: new developments in neurostereology and 3D imagery.

Authors:  M E Calhoun; P R Mouton
Journal:  J Chem Neuroanat       Date:  2001-05       Impact factor: 3.052

2.  Stereological length estimation using spherical probes.

Authors:  P R Mouton; A M Gokhale; N L Ward; M J West
Journal:  J Microsc       Date:  2002-04       Impact factor: 1.758

3.  Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

Authors:  J Van Dorpe; L Smeijers; I Dewachter; D Nuyens; K Spittaels; C Van Den Haute; M Mercken; D Moechars; I Laenen; C Kuiperi; K Bruynseels; I Tesseur; R Loos; H Vanderstichele; F Checler; R Sciot; F Van Leuven
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

Authors:  M A Chishti; D S Yang; C Janus; A L Phinney; P Horne; J Pearson; R Strome; N Zuker; J Loukides; J French; S Turner; G Lozza; M Grilli; S Kunicki; C Morissette; J Paquette; F Gervais; C Bergeron; P E Fraser; G A Carlson; P S George-Hyslop; D Westaway
Journal:  J Biol Chem       Date:  2001-03-15       Impact factor: 5.157

5.  Stereological studies of capillary length density in the frontal cortex of schizophrenics.

Authors:  Pawel Kreczmanski; Rainald Schmidt-Kastner; Helmut Heinsen; Harry W M Steinbusch; Patrick R Hof; Christoph Schmitz
Journal:  Acta Neuropathol       Date:  2005-05-10       Impact factor: 17.088

6.  Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.

Authors:  Elisabeth Tarkowski; Razao Issa; Magnus Sjögren; Anders Wallin; Kaj Blennow; Andrej Tarkowski; Pat Kumar
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

7.  Modification of human beta-globin locus PAC clones by homologous recombination in Escherichia coli.

Authors:  A M Imam; G P Patrinos; M de Krom; S Bottardi; R J Janssens; E Katsantoni; A W Wai; D J Sherratt; F G Grosveld
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

8.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

Authors:  M E Calhoun; P Burgermeister; A L Phinney; M Stalder; M Tolnay; K H Wiederhold; D Abramowski; C Sturchler-Pierrat; B Sommer; M Staufenbiel; M Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

9.  Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.

Authors:  Paula Grammas; Roma Ovase
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

10.  Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice.

Authors:  Paul H Wen; Xiang Shao; Zhiping Shao; Patrick R Hof; Thomas Wisniewski; Kevin Kelley; Victor L Friedrich; Lap Ho; Giulio M Pasinetti; Junichi Shioi; Nikolaos K Robakis; Gregory A Elder
Journal:  Neurobiol Dis       Date:  2002-06       Impact factor: 5.996

View more
  46 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

2.  Tol2 gene trap integrations in the zebrafish amyloid precursor protein genes appa and aplp2 reveal accumulation of secreted APP at the embryonic veins.

Authors:  Hsin-Kai Liao; Ying Wang; Kristin E Noack Watt; Qin Wen; Justin Breitbach; Chelsy K Kemmet; Karl J Clark; Stephen C Ekker; Jeffrey J Essner; Maura McGrail
Journal:  Dev Dyn       Date:  2012-02       Impact factor: 3.780

3.  Pericytic Laminin Maintains Blood-Brain Barrier Integrity in an Age-Dependent Manner.

Authors:  Jyoti Gautam; Yu Cao; Yao Yao
Journal:  Transl Stroke Res       Date:  2019-06-18       Impact factor: 6.829

Review 4.  The vascular basement membrane in the healthy and pathological brain.

Authors:  Maj S Thomsen; Lisa J Routhe; Torben Moos
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

5.  Influence of membrane cholesterol and substrate elasticity on endothelial cell spreading behavior.

Authors:  Zhongkui Hong; Ilker Ersoy; Mingzhai Sun; Filiz Bunyak; Paul Hampel; Zhenling Hong; Zhe Sun; Zhaohui Li; Irena Levitan; Gerald A Meininger; Kannappan Palaniappan
Journal:  J Biomed Mater Res A       Date:  2012-12-13       Impact factor: 4.396

6.  The product of the γ-secretase processing of ephrinB2 regulates VE-cadherin complexes and angiogenesis.

Authors:  Noel A Warren; Georgios Voloudakis; Yonejung Yoon; Nikolaos K Robakis; Anastasios Georgakopoulos
Journal:  Cell Mol Life Sci       Date:  2018-02-10       Impact factor: 9.261

7.  Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

Authors:  Alex E Roher; Chera L Maarouf; Michael Malek-Ahmadi; Jeffrey Wilson; Tyler A Kokjohn; Ian D Daugs; Charisse M Whiteside; Walter M Kalback; Mimi P Macias; Sandra A Jacobson; Marwan N Sabbagh; Bernardino Ghetti; Thomas G Beach
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

8.  Presenilin-1 regulates induction of hypoxia inducible factor-1α: altered activation by a mutation associated with familial Alzheimer's disease.

Authors:  Rita De Gasperi; Miguel A Gama Sosa; Stella Dracheva; Gregory A Elder
Journal:  Mol Neurodegener       Date:  2010-09-23       Impact factor: 14.195

9.  miR-195 regulates SIRT1-mediated changes in diabetic retinopathy.

Authors:  Rokhsana Mortuza; Biao Feng; Subrata Chakrabarti
Journal:  Diabetologia       Date:  2014-02-26       Impact factor: 10.122

Review 10.  Establishment and Dysfunction of the Blood-Brain Barrier.

Authors:  Zhen Zhao; Amy R Nelson; Christer Betsholtz; Berislav V Zlokovic
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.